High Throughput Screening Market to Witness Steady Growth in the Near Future

 Market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the HTS market.

The global High-Throughput Screening (HTS) Market size is projected to reach USD 26.4 billion by 2025 from USD 15.3  billion in 2020, at a CAGR of 11.5% during the forecast period.

Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

Market Segmentation: -

The consumables segment accounted for the largest share of the product & services segment in the high-throughput screening market in 2019.

On the basis type ofproduct & service, the high-throughput screening market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

The drug discovery segment accounted for the largest share of the application segment in the high-throughput screening market in 2019. 

Based on application, the high-throughput screening market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the high-throughput screening market in 2019. The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

Key Market Drivers: –
1 Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
2 Government Funding and Venture Capital Investments
3 Increasing R&D Spending
4 Technological Advancements in the HTS market

Regional Analysis: -

In 2019, Asia Pacific region accounted for the fastest-growing region of the high-throughput screening market. It is also estimated to grow at the highest CAGR in the high-throughput screening market during the forecast period, this is mainly due to factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the HTS market in this region.

Inquiry Before Buying:-  https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=134981950

Top key Players: -

Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US),  Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg).

Genomics Market - Global Growth Drivers & Opportunities | MarketsandMarkets

 "Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025", published by MarketsandMarkets™, the global Genomics Market is projected to reach USD 54.4 billion by 2025 from USD 22.7 billion in 2020, at a CAGR of 19.0% during the forecast period.

Browse in-depth TOC on "Genomics Market"

114 – Tables
34 – Figures
194 – Pages

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=613

Scope of the Report:

The study categorizes the market into the following segments and subsegments:

By Product & Service

• Systems & Software
• Consumables
• Services

By Technology

• Sequencing
• PCR
• Nucleic Acid Extraction and Purification
• Microarray
• Other Technologies

By Application 

• Drug Discovery and Development
• Diagnostics
• Agriculture and Animal Research
• Other Applications

By End User

•  Hospitals & Clinics  
• Research Centers and Academic & Government Institutes,
• Pharmaceutical & Biotechnology Companies
• Other End Users

By Region

• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• The Middle East and Africa

The major factors driving the growth of this market include the increasing government funding to support genomics projects, the growing incidence of cancer and increasing applications of NGS in cancer research, the entry of new players and start-ups in the genomics product and service market, and the growing application areas of genomics.

The next generation sequencing sub segment accounted for the largest share of the sequencing technology segment in the genomics market in 2019.

Based on technology, the market is segmented into sequencing technologies, PCR, nucleic acid extraction and purification, microarrays, and other technologies. The sequencing segment is further sub segmented into next-generation sequencing (NGS) and other sequencing technologies. In 2019 the next-generation sequencing technology accounted for the largest share of the genomics market. The advantages associated with NGS such as ultra-high-throughput, scalability, and high speed, enable researchers to perform a wide variety of applications, including animal breeding, agriculture, and human genomics. This is one of the major drivers of this segment.

The hospitals and clinics segment accounted for the largest share of the end user segment in the genomics product and service market in 2019.

Based on end users, the genomics market is segmented into hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies, and other end users. In 2019, the hospitals & clinics segment accounted for the largest share of the market. Hospitals & clinics are shifting from traditional genomic testing methods to cost-effective and more sensitive methods, such as whole-exome sequencing, which is a major factor driving the market growth.

Inquiry Before Buying: -https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=613

The Asia Pacific region is the fastest growing region of the genomics market in 2019.

In 2019, the Asia Pacific region accented for the fastest growing region of the market. It is also estimated to grow at the highest CAGR in the genomics product and service market during the forecast period, mainly due to favorable government support for genomics projects, increasing awareness about newer genomics technologies such as NGS, and expansions of key players to strengthen their presence in the APAC region.

Some of the leading players operating in the genomics product and service market are Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), and BGI (China).

Flow Cytometry Market Growth Drivers & Opportunities | MarketsandMarkets

 Flow Cytometry Market is projected to grow from USD 4.7 billion in 2022 to USD 6.9 billion by 2027, at a CAGR of 8.1% from 2022 to 2027 according to a new report by MarketsandMarkets™. The growth of the Flow Cytometry Market is largely driven by the rising prevalence of HIV/AIDS and cancer, growing adoption of flow cytometry techniques in research activities, increasing public-private initiatives in immunology and immuno-oncology research, and rising technological advancements in flow cytometry software.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584

Browse in-depth TOC on "Flow Cytometry Market"

331 – Tables
37 – Figures
332 – Pages

Reagents & consumables segment held major share in Flow Cytometry Market in 2021.

Based on product & service, the market is segmented into reagents & consumables, instruments, software, services, and accessories. Reagents & consumables accounted for the largest share in the market in 2021. The large share of this segment can primarily be attributed to the growing use of flow cytometry techniques in clinical & research applications.

Research application segment dominated the global Flow Cytometry Market in 2021.

Based on applications, the market is segmented into research, clinical, and industrial applications.  In 2021, the research applications segment accounted for the largest share in the global market.  The large share of the research applications segment is mainly due to the growing adoption of flow cytometry in research activities and the increasing availability of flow cytometry services, such as cell sorting, cell cycle analysis, and apoptosis.

Inquiry Before Buying: 
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=65374584

North America has registered fastest growth rate during the forecast period in Flow Cytometry Market

Geographically, the Flow Cytometry Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share in the global market in 2021. The large share of North America in the market is largely driven by the presence of key market players and increasing public-private initiatives for research activities. The market in the Asia Pacific region is expected to grow at the highest CAGR of 8.6% during the forecast period. The high growth rate of the APAC region can be attributed to the growing pharmaceutical industry; increasing participation of emerging markets in flow cytometry-based research; expansion of research infrastructure; and increasing public-private initiatives to boost advanced proteomics research in the region.

The prominent players in the Flow Cytometry Market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), and Luminex Corporation (US). These companies have adopted organic and inorganic growth strategies, such as product launches and acquisitions, to maintain their leading positions in the market.

Urology Devices Market: Rising incidence and prevalence of urological conditions

 Over the last few decades, the incidence and prevalence of urological conditions, such as chronic kidney disease (CKD), end-stage renal disease (ESRD), urinary incontinence, kidney and ureteral stones, and bladder and prostate cancer, have increased significantly across the globe. According to the Global Forum on Incontinence, 4−8% of the global population (approximately 400 million people) were affected by urinary incontinence in 2018. Urology-related consumables such as urinary catheters are used to manage incontinence, which cannot be treated or managed with medicines or surgery. The prevalence of urinary incontinence is expected to grow due to the growing aging population and the increasing incidence of obesity, as these are the two major risk factors for urinary incontinence. This is expected to fuel market growth.

The global urology devices market is projected to reach USD 46.4 billion by 2026 from USD 38.0 billion in 2021, at a CAGR of 4.1%.

Download PDF Brochure: -  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212

Market Segmentation:

The urology devices market is segmented into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other applications based on application. In 2020, the urological cancer and BPH segment accounted for the highest growth rate. This can be attributed to the rising incidence of urological cancers coupled with the growing number of cancer-related surgeries.

Based on product, the market is segmented into instruments and consumables & accessories. The instruments segment accounted for the largest share of the market in 2020. This segment includes dialysis devices, endoscopes, laser and lithotripsy devices, robotic systems, endovision and imaging systems, insufflators, endoscopy fluid management systems, and urodynamic systems.

Based on end users, the market is segmented into hospitals, ASCs, and clinics; dialysis centers; and home care settings. In 2020, the hospitals, ASCs, and clinics segment accounted for the largest share of the market. The improving healthcare infrastructure in developing countries such as India, the rising number of target procedures, and the rising number of surgeries are the major factors driving this segments growth.

Regional Analysis:

The Urology Devices market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the urology devices market.

Inquiry Before Buying: -https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=173062212

Top Key Players:-

The major players operating in this urology devices market are  Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Stryker Corporation (US), KARL STORZ (Germany), Cook Medical (US), Intuitive Surgical (US), Medtronic plc (Ireland), Cardinal Health (US), Teleflex Incorporated (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Balton Sp. z o.o. (Poland), Dialife SA (Switzerland), Maxer Endoscopy GmbH (Germany), Vimex Sp. z o.o. (Poland), Amsino International, Inc. (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Medispec (US), Medical Technologies of Georgia (Georgia), EndoMed Systems GmbH (Germany), Hunter Urology (England), J and M Urinary Catheters LLC (US), and Ribbel International Limited (India).

Wearable Injectors Market: Increasing demand for biologics and mAbs

 Growth in Wearable injectors market is mainly driven by factors such as the shift of healthcare delivery toward homecare due to COVID-19, advantages of wearable injectors in the administration of various drugs, the rising prevalence of chronic diseases (such as cancer, diabetes, and CVD), favorable reimbursement scenario in major markets, and technological advancements in injector devices. However, the preference for alternative drug delivery modes, high costs, and a poor reimbursement structure in developing countries are expected to limit the adoption of wearable injectors to a certain extent.

The global Wearable injectors market is projected to reach USD 11.6 billion by 2026 from USD 7.3 billion in 2021, at a CAGR of 9.9% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004

Market Segmentation:

By type, the global market is segmented into on-body injectors and off-body injectors. The on-body injectors segment accounted for the largest share in the forecast year. The large share of this segment can be attributed to the patients ease to deliver a precise amount of drug to the body over a controlled period of time.

Based on technology, the wearable injectors market is segmented into spring-based, motor-driven, rotary pump, expanding battery, and other technologies. The spring-based technology segment accounted for the largest share in the forecast period. The large share of this segment can be attributed to the rising demand for adhesive patches, as these devices are user-friendly and enable patients to accurately deliver the required drug subcutaneously.

Based on therapy, the wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (such as Parkinson's disease, thalassemia, and primary immunodeficiency disorders). The diabetes segment accounted for the largest share in the forecast period. The large share of this segment can be attributed to The high burden of diabetes across the globe, coupled with the growing availability of wearable injectors for the treatment of these diseases, is driving the growth of this market segment.

Based on end user, the market is segmented into hospitals and clinics and home healthcare settings. The hospitals and clinics segment accounted for a larger market share during the forecast period. The large share of this segment can primarily be attributed to the rising preference for the self-administration of medication and the increasing need to curb healthcare costs. In addition, the growing demand for technologically developed drug delivery approaches, which lower the hospitalization rate and require minimal expertise, is expected to boost the growth of the home healthcare settings segment.

Regional Analysis: -

The wearable injector market in North America accounted for the largest market during the forecast period. The large share of North America in this market is to the rising prevalence of chronic and lifestyle-related diseases and the presence of advanced healthcare infrastructure in the region. However, the Europe market is estimated to grow at the highest CAGR during the forecast period owing to factors such as the Increasing prevalence of chronic diseases, Government support for drug development in Germany, Rising focus on biosimilar innovation in the UK, Favorable reimbursement scenario for various treatment options in France.

Inquiry Before Buying  : https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=100771004

Top Key Players :-

Prominent players in the wearable injectors market include Becton, Dickinson and Company(US), Ypsomed(Switzerland), Amgen(US), Subcuject(Denmark), Enable Injections, Inc(US), Medtronic Plc(Ireland), Insulet Corporation(US), United Therapeutics Corp (Us), CeQur SA(Switzerland), Sensile Medical(Switzerland).

What are the newest trends and advancements in the hematology analyzers and reagents market?

 The increasing incidence of blood disorders and the growth in the number of blood donation are the major factors driving the growth of the global hematology analyzers and reagents market. Technological advancements in hematology analyzers and reagents and the integration of flow cytometry techniques with hematology analyzers are also expected to support the growth of this market during the forecast period.

The global hematology analyzers and reagents market size is expected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146

Market Segmentation: -

On the basis of products & services, the hematology analyzers and reagents market is classified into hematology, hemostasis, and immunohematology products & services. The hematology products & services segment is projected to grow at the highest growth rate during the forecast period. Factors such as the increasing adoption of POC testing hematology analyzers in emerging economies, the launch of technologically advanced hematology products, the increasing preference for automation, the growing trend of the "reagent rental" business model, and the rising availability of a wide range of services from major hematology providers are driving the growth of this segment.

By end user, the hematology analyzers and reagents market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the market due to factors such as the increasing awareness about hematology testing, shift from manual testing to automated testing, and the competitive benefits offered by these providers as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management of sample collection).

Regional Analysis:

North America accounted for the largest share of the market in 2019. This can be attributed to the rising incidence of patients suffering from blood disorders, the growing prevalence of target diseases, and the rising demand for blood transfusions in the region.

Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=153222146

Top Key Players: -

The major players in the global hematology analyzers and reagents market are Sysmex Corporation (Japan), Abbott Laboratories (US), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland).